Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1983 Jul;41(1):33–38. doi: 10.1128/iai.41.1.33-38.1983

Candida albicans-induced agglutinin and immunoglobulin E responses in mice.

G E Winterrowd, J E Cutler
PMCID: PMC264738  PMID: 6190755

Abstract

Mice varied in their ability to make detectable antibody responses to cell surface determinants of Candida albicans depending upon the antigen preparation and the immunization schedule used. Immunoglobulin M (IgM) appeared to be the major class of antibody responsible for the C. albicans-agglutinating activity of the immune sera. Various inbred strains of mice injected with a ribosomal fraction from C. albicans produced a low titer (average, 4 to 8) of yeast cell agglutinins and a higher titer (64 to 512) of IgE antibodies detected by passive cutaneous anaphylaxis (PCA) in rats. The two kinds of antibodies appeared to be specific for different antigens because the agglutinin, but not IgE, could be removed by absorbing the serum with a polysaccharide from the cell wall of C. albicans, but the polysaccharide did not provoke the PCA reaction. C. albicans-specific IgE antibodies showed cross-reactivity (PCA) with ribosomal antigens from a strain of C. albicans and C. tropicalis, but PCA reactions could not be elicited with similar antigen preparations from other yeast species. IgE responses were also detected in over 20% of the mice infected intravenously or intraperitoneally with live C. albicans.

Full text

PDF
33

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Carlson E. Synergistic effect of Candida albicans and Staphylococcus aureus on mouse mortality. Infect Immun. 1982 Dec;38(3):921–924. doi: 10.1128/iai.38.3.921-924.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Cox R. A., Arnold D. R. Immunoglobulin E in coccidioidomycosis. J Immunol. 1979 Jul;123(1):194–200. [PubMed] [Google Scholar]
  3. Cox R. A., Arnold D. R. Immunoglobulin E in histoplasmosis. Infect Immun. 1980 Jul;29(1):290–293. doi: 10.1128/iai.29.1.290-293.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cutler J. E., Friedman L., Milner K. C. Biological and chemical characterization of toxic substances from Candida albicans. Infect Immun. 1972 Oct;6(4):616–627. doi: 10.1128/iai.6.4.616-627.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Cutler J. E., Lloyd R. K. Enhanced antibody responses induced by Candida albicans in mice. Infect Immun. 1982 Dec;38(3):1102–1108. doi: 10.1128/iai.38.3.1102-1108.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Eisenstein T. K. Evidence for O antigens as the antigenic determinants in "ribosomal" vaccines prepared from Salmonella. Infect Immun. 1975 Aug;12(2):364–377. doi: 10.1128/iai.12.2.364-377.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Feit C., Tewari R. P. Immunogenicity of Ribosomal Preparations from Yeast Cells of Histoplasma capsulatum. Infect Immun. 1974 Nov;10(5):1091–1097. doi: 10.1128/iai.10.5.1091-1097.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Field L. H., Parker C. D., Manclark C. R., Berry L. J. Evaluation of a ribosomal vaccine against pertussis. Infect Immun. 1979 May;24(2):346–351. doi: 10.1128/iai.24.2.346-351.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hector R. F., Domer J. E., Carrow E. W. Immune responses to Candida albicans in genetically distinct mice. Infect Immun. 1982 Dec;38(3):1020–1028. doi: 10.1128/iai.38.3.1020-1028.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Kirkpatrick C. H., Smith T. K. Chronic mucocutaneous candidiasis: immunologic and antibiotic therapy. Ann Intern Med. 1974 Mar;80(3):310–320. doi: 10.7326/0003-4819-80-3-310. [DOI] [PubMed] [Google Scholar]
  11. Levy R., Segal E., Eylan E. Protective immunity against murine candidiasis elicited by Candida albicans ribosomal fractions. Infect Immun. 1981 Mar;31(3):874–878. doi: 10.1128/iai.31.3.874-878.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Lieberman M. M. Pseudomonas ribosomal vaccines: preparation, properties, and immunogenicity. Infect Immun. 1978 Jul;21(1):76–86. doi: 10.1128/iai.21.1.76-86.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Lynn M., Tewari R. P., Solotorovsky M. Immunoprotective activity of ribosomes from Haemophilus influenzae. Infect Immun. 1977 Feb;15(2):453–460. doi: 10.1128/iai.15.2.453-460.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. MCPHERSON C. W. REDUCTION OF PSEUDOMONAS AERUGINOSA AND COLIFORM BACTERIA IN MOUSE DRINKING WATER FOLLOWING TREATMENT WITH HYDROCHLORIC ACID OR CHLORINE. Lab Anim Care. 1963 Oct;13:737–744. [PubMed] [Google Scholar]
  15. Mathur S., Goust J. M., Horger E. O., 3rd, Fudenberg H. H. Immunoglobulin E anti-Candida antibodies and candidiasis. Infect Immun. 1977 Oct;18(1):257–259. doi: 10.1128/iai.18.1.257-259.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Moser S. A., Domer J. E. Effects of cyclophosphamide on murine candidiasis. Infect Immun. 1980 Feb;27(2):376–386. doi: 10.1128/iai.27.2.376-386.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Mota I., Wong D. Homologous and heterologous passive cutaneous anaphylactic activity of mouse antisera during the course of immunization. Life Sci. 1969 Aug 15;8(16):813–820. doi: 10.1016/0024-3205(69)90099-x. [DOI] [PubMed] [Google Scholar]
  18. Mourad S., Friedman L. Passive immunization of mice against Candida albicans. Sabouraudia. 1968 Feb;6(2):103–105. [PubMed] [Google Scholar]
  19. Ovary Z., Caiazza S. S., Kojima S. PCA reactions with mouse antibodies in mice and rats. Int Arch Allergy Appl Immunol. 1975;48(1):16–21. doi: 10.1159/000231289. [DOI] [PubMed] [Google Scholar]
  20. Pearsall N. N., Adams B. L., Bunni R. Immunologic responses to Candida albicans. III. Effects of passive transfer of lymphoid cells or serum on murine candidiasis. J Immunol. 1978 Apr;120(4):1176–1180. [PubMed] [Google Scholar]
  21. Poor A. H., Cutler J. E. Partially purified antibodies used in a solid-phase radioimmunoassay for detecting candidal antigenemia. J Clin Microbiol. 1979 Mar;9(3):362–368. doi: 10.1128/jcm.9.3.362-368.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Poulain D., Tronchin G., Lefebvre B., Husson M. O. Antigenic variability between Candida albicans blastospores isolated from healthy subjects and patients with Candida infection. Sabouraudia. 1982 Sep;20(3):173–177. [PubMed] [Google Scholar]
  23. Rinaldi M. G. Use of potato flakes agar in clinical mycology. J Clin Microbiol. 1982 Jun;15(6):1159–1160. doi: 10.1128/jcm.15.6.1159-1160.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Rogers T. J., Balish E. Immunity to Candida albicans. Microbiol Rev. 1980 Dec;44(4):660–682. doi: 10.1128/mr.44.4.660-682.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Rubin G. M. Preparation of RNA and ribosomes from yeast. Methods Cell Biol. 1975;12:45–64. doi: 10.1016/s0091-679x(08)60951-6. [DOI] [PubMed] [Google Scholar]
  26. Schalla W. O., Johnson W. Immunogenicity of ribosomal vaccines isolated from group A, type 14 Streptococcus pyogenes. Infect Immun. 1975 Jun;11(6):1195–1202. doi: 10.1128/iai.11.6.1195-1202.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Segal E., Levy R., Eylan E. Antibody formation in experimental immunizations with Candida albicans ribosomal fractions. Mycopathologia. 1978 Oct 16;64(2):121–123. doi: 10.1007/BF00440972. [DOI] [PubMed] [Google Scholar]
  28. Simon M. R., Tubergen D., Cassidy J., Silva J., Jr, Magilavy D. Chronic mucocutaneous candidiasis clinically exacerbated by type I hypersensitivity. Clin Immunol Immunopathol. 1979 Sep;14(1):56–63. doi: 10.1016/0090-1229(79)90125-9. [DOI] [PubMed] [Google Scholar]
  29. Swendsen C. L., Johnson W. Humoral immunity to Streptococcus pneumoniae induced by a pneumococcal ribosomal protein fraction. Infect Immun. 1976 Aug;14(2):345–354. doi: 10.1128/iai.14.2.345-354.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Vardinon N., Segal E., Schwartz J., Eylan E. Mast cell sensitizing antibody (MCSAb) response in experimental candidiasis: chromatographic studies. Acta Allergol. 1975 Jul;30(2-3):120–125. doi: 10.1111/j.1398-9995.1975.tb01335.x. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES